Neural Analytics landed a $3 million grant from the National Institutes of Health for the diagnostic and monitoring technology it’s developing for traumatic brain injury and stroke, the company reported. The NIH’s Small Business Innovation Research program funded the grant. Los Angeles-based Neural Analytics, founded in 2013, develops technology to measure and track brain health, […]
Funding Roundup
Titan Medical sets $8m to $12m range on overnight offering for Sport surgical bot
Titan Medical (TSE:TMD) said yesterday that it hopes to raise between $8 million and $12 million via an overnight offering it plans to use to restart the development program for its Sport robot-assisted surgery platform. Toronto-based Titan Medical said the offering, priced at 46.1¢ (C60¢) per unit, will involve between nearly 17.1 million and 26.8 million units. Each unit […]
Credence MedSystems raises $15m for safe-syringe drug delivery
Credence MedSystems announced today that it raised $15 million in a Series A round to fund continued development and commercialization of its injectable drug-delivery device. The company’s flagship device is the Credence Companion safety syringe, a pre-fillable device sold to drug manufacturers for use with injectable medications. The user injects their medication, gets a cue […]
Acelity CFO Casey departs on the eve of $1.75B debt offering, $450m refi
UPDATED Sept. 13, 2016, with details on Casey’s move to Lending Club. Acelity CFO Tom Casey is stepping down effective Sept. 16 for the chief finance spot at Lending Club, as Acelity prepares for a $1.75 billion debt offering and a $675 refinancing, the wound care giant said today. Casey is slated to be replaced on an interim […]
Chrono Therapeutics closes $48m Series B for smart nicotine patch
Hayward, Calif.-based startup Chrono Therapeutics reportedly raised $47.6m in a Series B round, led by Kaiser Permanente Ventures. The money, Chrono CEO Alan Levy told Forbes, is to fund clinical trials of a transdermal smoking cessation patch. The company is preparing for a large, Phase II efficacy study of the technology. Unlike normal nicotine patches, Chrono said […]
Titan Medical prices overnight offering
Titan Medical (TSE:TMD) today priced an overnight offering at 46.1¢ (C60¢) per unit, saying it plans to use the proceeds to continue developing its Sport robot-assisted surgery platform. Each unit in the offering consists of a share of stock and a 5-year warrant to buy another share at 57.6¢ (C75¢). Toronto-based Titan did not say how many […]
Obalon Therapeutics reveals PMA for weight-loss balloon with $75m IPO registration
UPDATED Sept. 12, 2016, with comment on PMA from Obalon. Obalon Therapeutics today registered for an initial public offering worth as much as $75 million, revealing in the process that it won pre-market approval from the FDA for its ingestible, gas-filled weight-loss balloon and plans to have it on the U.S. market in early 2017. Carlsbad, Calif.-based […]
OEMs get in on $10m Series C for biosensor maker HMicro
HMicro said today that “dominant strategic OEM partners” joined a $10.2 million Series C round for the biosensor platform it’s developing for commercialization. Get the whole story on our sister site, Medical Design & Outsourcing.
410 Medical Innovations raises $2m for LifeFlow rapid infuser
410 Medical Innovations said in a regulatory filing today that it raised a funding round worth $2.2 million. Durham, N.C.-based 410 Medical developed the LifeFlow rapid infuser for critically ill patients needing urgent fluid delivery. The device is designed to allow front-line healthcare providers to deliver 1 liter of crystalloid fluid through a 20-gauge IV catheter in 5 minutes. Some […]
Boston Scientific puts $25m into venous stent maker Veniti
Veniti said today that Boston Scientific (NYSE:BSX) put up $25 million for its Series D round, which it plans to use to back a clinical trial of its Vici venous stent. Veniti’s 200-patient, 60-month Virtus trial, run under an investigational device exemption from the FDA, is a single-arm safety & efficacy study with a main safety endpoint of major adverse […]
Insulet plans $250m debt offering
Insulet (NSDQ:PODD) said yesterday that it plans to fund a new, automated U.S. plant in part with the proceeds from a $250 million debt offering. Billerica, Mass.-based Insulet, which makes the Omnipod insulin management system for treating diabetes, said the private placement offering of senior notes due in 2021 includes an option on another $37.5 million worth […]